Mitogenic activity of BaF3 cells expressing wild-type FGFR2 (circles)
and S252W mutant FGFR2 (squares) after treatment with different FGFs.
(A, C, E, and G) Comparison of wild-type
and mutant FGFR2c. (B, D, F, and H)
Comparison of wild-type and mutant FGFR2b. Each stably selected
polyclonal cell pool was treated with FGF1, FGF2, FGF6 (not shown),
FGF7, FGF9, and FGF10 (not shown), as indicated.